Hydrazinomethyl, HYDR zonomethyl and 5-membered heterocylic compounds which act as MTOR inhibitors and their use as anti cancer agents

Details for Australian Patent Application No. 2006217742 (hide)

Owner KuDOS Pharmaceuticals Limited

Inventors Cockcroft, Xiao-ling Fan; Menear, Keith Allan; Smith, Graeme Cameron Murray; Hummersone, Marc Geoffrey; Gomez, Sylvie

Agent Davies Collison Cave

Pub. Number AU-A-2006217742

PCT Pub. Number WO2006/090167

Priority 0503962.3 25.02.05 GB; 60/656,193 25.02.05 US

Filing date 24 February 2006

Wipo publication date 31 August 2006

International Classifications

C07D 251/70 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/090167 Priority application(s): WO2006/090167

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006217744-2,4-diamino-pyridopyrimidine derivatives and their use as MTOR inhibitors

2006217738-Quinazoline derivatives as tyrosine kinase inhibitors